Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

NCT03050086 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Papulopustular Rosacea

Interventions

DRUG: BPX-04 1% minocycline topical gel
DRUG: BPX-04 2% minocycline topical gel
DRUG: BPX-04 vehicle topical gel

Sponsor

BioPharmX, Inc.